IVD Medical Holding Ltd (HKG: 1931), a leading in vitro diagnostic (IVD) company based in China, has announced the signing of a non-binding Memorandum of Understanding (MoU) with a fellow Chinese IVD company, which is yet to be named. The MoU outlines the intention to explore potential collaboration opportunities, including but not limited to business cooperation, technical exchange, equity investment, and capital increase or injection.
The prospective partner, established in 2011, specializes in the chemiluminescence field of IVD and has developed an alkaline phosphatase-based chemiluminescence technology platform. Their testing menu encompasses a broad range of diagnostic areas, including sex hormones, tumor markers, thyroid function hormones, renal function testing, bone metabolism, myocardial markers, hypertension, and liver fibrosis.- Flcube.com
